Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ventana files patent litigation against Vision
In its complaint, Ventana alleges that Vision's Bond X and maX OCR instruments infringe its patent for scheduling algorithms which enable optimal sequencing of multiple tests. The complaint
In its complaint, Ventana alleges that Vision's Bond X and maX OCR instruments infringe its patent for scheduling algorithms which enable optimal sequencing of multiple tests. The complaint
This trial specifically examined the effects of the ultrasonic transmission utilized in the U-Strip insulin delivery system upon the skin of Type-2 diabetic patients. The goal of this
The findings showed that INGN 241, in combination with Avastin produced a complete therapeutic effect in models of lung cancer. INGN 241 and Avastin each inhibit the development
The studies evaluated denosumab and a sclerostin antibody. These antibodies target key proteins responsible for the regulation of bone destruction and formation. The research was presented at the
Health Canada has approved the amendment of the trial on ECO-4601. ECO-4601 is a potent inhibitor of the RAS genes which is an important validated target for anticancer
The study carried out by the University of Bath and the University of Texas demonstrated that the drug could lead to depressive behavior in mice. Scientists gave Roaccutane
Ondansetron tablets are the generic version of GlaxoSmithKline’s Zofram tablets. Zofram belongs to a class of antiemetics that treat nausea caused by cancer chemotherapy, radiation therapy, anesthesia, and
Paliperidone ER, a new chemical entity, is the first and only atypical antipsychotic to use OROS extended-release technology. The OROS technology was developed by subsidiaries of Johnson &
“This is an important advancement for our existing technology because it will allow us to reach an even broader population,” said Dr Rick Bright, Novavax’s vice president of
Glivec is used in the treatment of a rapidly progressive leukemia and hard-to-treat solid cancer tumors. Both are rare and potentially life-threatening diseases with few, if any, approved